Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             483 results found
no title author magazine year volume issue page(s) type
1 ABRAXANE DESENSITIZATION Bansal, K.

129 5S p. S85-S86
article
2 A CASE OF ACUTE FOOD PROTEIN-INDUCED ENTEROCOLITIS (FPIES) TO FISH, TURKEY, AND DUCK Lee, A.

129 5S p. S148-S149
article
3 A CASE OF ANAPHYLAXIS TO FOSAPREPITANT Chhiba, K.

129 5S p. S90
article
4 A CASE OF ANAPHYLAXIS TO SUGAMMADEX SKIN PRICK TESTING Dittus, M.

129 5S p. S86
article
5 A CASE OF AN UNRECOGNIZED AUTOINFLAMMATORY DISEASE Patel, P.

129 5S p. S160
article
6 A CASE OF DIFFICULT TO DIAGNOSE C1INH NORMAL HAE Balandia, M.

129 5S p. S111
article
7 A CASE OF DOCK8 DEFICIENCY TREATED WITH DUPILUMAB Anderson, M.

129 5S p. S141
article
8 A CASE OF HEREDITARY ALPHA TRYPTASEMIA MASQUERADING AS CHEMOTHERAPY HYPERSENSITIVITY REACTION Monahan, R.

129 5S p. S95
article
9 A CASE OF HEREDITARY ANGIOEDEMA SUBTYPE SWITCH Patadia, R.

129 5S p. S117-S118
article
10 A CASE OF HYPEREOSINOPHILIA IN A PATIENT WITH EVANS SYNDROME Freigeh, G.

129 5S p. S134
article
11 A CASE OF INTRA-OPERATIVE ANAPHYLAXIS TO LATEX IN A PULMONARY ARTERY CATHETER Ruiz, J.

129 5S p. S98
article
12 A CASE OF MUCOUS MEMBRANE PEMPHIGOID PRESENTING TO ALLERGY CLINIC AS AN ADVERSE FOOD REACTION Arthur, A.

129 5S p. S124
article
13 A CASE OF PERSISTENT SEVERE ASTHMA DESPITE USE OF MULTIPLE BIOLOGICS Shapero, M.

129 5S p. S119
article
14 A CASE OF PULMONARY EMBOLISM POST COVID-19 INFECTION IN A PATIENT WITH STAT3 MUTATION Blunk, H.

129 5S p. S121-S122
article
15 A CASE OF RECURRENT HISTIOCYTOID SWEET SYNDROME Balasubramanyam, S.

129 5S p. S157
article
16 A CASE OF RECURRENT HIVES WITH LACTATION Dharia, T.

129 5S p. S111
article
17 A CASE OF RECURRENT IDIOPATHIC ANAPHYLAXIS WHILE ON HIGH-DOSE ANTIHISTAMINE THERAPY Gill, N.

129 5S p. S98
article
18 A CASE OF RECURRENT RESPIRATORY FAILURE AND EOSINOPHILIA CAUSED BY PAPILLARY RENAL CELL CARCINOMA Kudlaty, E.

129 5S p. S119
article
19 A CASE OF SYSTEMIC MASTOCYTOSIS IN A 72-YEAR OLD FEMALE PRESENTING WITH GASTROINTESTINAL BLEEDING Sianghio, N.

129 5S p. S131
article
20 A CASE OF TOXIC EPIDERMAL NECROLYSIS DURING IMMUNE CHECKPOINT INHIBITOR AND PLATIN TREATMENT FOR CANCER Din, R.

129 5S p. S94-S95
article
21 A CASE SERIES: CHRONIC INDUCIBLE URTICARIA FOLLOWING COVID-19 INFECTION AND MRNA VACCINE Hellu, T.

129 5S p. S113
article
22 A CASE SERIES OF EOSINOPHILIC ESOPHAGITIS MANAGEMENT IN PEDIATRIC PATIENTS UNDERGOING FOOD ALLERGEN ORAL IMMUNOTHERAPY Hardwick, G.

129 5S p. S66
article
23 A CASE SERIES OF HLA-B*58:01 SPECIFIC ALLOPURINOL-INDUCED DRESS/DIHS Diaz, A.

129 5S p. S97-S98
article
24 A CHRONIC GRANULOMATOUS DISEASE-LIKE PRESENTATION OF AUTOSOMAL RECESSIVE PROTEIN KINASE C DELTA DEFICIENCY Dunham, T.

129 5S p. S137
article
25 A CURIOUS CASE OF ACQUIRED ANGIOEDEMA: DIAGNOSIS AND MANAGEMENT OF C1-INH-AAE WITHOUT AN UNDERLYING CONDITION Donahue, M.

129 5S p. S113-S114
article
26 ACUTE STROKE DURING PENICILLIN DESENSITIZATION DUE TO JARISCH HERXHEIMER Bhatti, S.

129 5S p. S101
article
27 A DELAYED DRUG RASH IN A PATIENT WITH ULCERATIVE COLITIS: INFLIXIMAB-INDUCED PSORIASIS. Hanlon, E.

129 5S p. S88
article
28 A DISCUSSION OF THE REFRACTORY PERIOD IN VENOM IMMUNOTHERAPY Deendyal, A.

129 5S p. S107
article
29 ADULT-ONSET ALLERGY TO SHRIMP IS ASSOCIATED WITH INCREASED BMI Pathinathan, J.

129 5S p. S66
article
30 ADVERSE REACTION TO TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD): ANAPHYLAXIS OR NOT? Wang, Z.

129 5S p. S103-S104
article
31 A LEAP FORWARD IN EVALUATION OF PEANUT ALLERGY IN A CHILD WITH SEVERE ATOPIC DERMATITIS Nevid, M.

129 5S p. S148
article
32 ALLERGIC CONTACT DERMATITIS TO 2-OCTYL CYANOACRYLATE CONFIRMED BY PATCH TESTING: A PEDIATRIC CASE SERIES Shah, I.

129 5S p. S73-S74
article
33 ALLERGY/IMMUNOLOGY FELLOWSHIP PROGRAMS AND DEPARTMENTS, AND THEIR SOCIAL MEDIA PRESENCE: A 4 YEAR COMPARISON Dimova, M.

129 5S p. S70
article
34 ALLERGY-RELATED HEALTHCARE RESOURCE USE AND COSTS IN PATIENTS WITH MULTIPLE VERSUS SINGLE FOOD ALLERGIES Gupta, R.

129 5S p. S60
article
35 ALPHA-GAL SYNDROME ON EASTERN LONG ISLAND: IGE RATIOS MORE GENERALIZABLE THAN ALPHA-GAL SIGE ALONE. Heffes-Doon, A.

129 5S p. S6
article
36 ANAPHYLACTIC REACTION TO OMEPRAZOLE AFTER NEGATIVE PANTOPRAZOLE ALLERGY TESTING Wilson, C.

129 5S p. S86-S87
article
37 ANAPHYLAXIS TO CRICKETS, CROSS REACTIVITY TO HOUSE DUST MITE AND ASSOCIATED COFACTORS. CASE REPORT Félix, D. Verduzco

129 5S p. S92
article
38 AN ATYPICAL CAUSE OF EOSINOPHILIA AND HYPOCOMPLEMENTEMIA Garcia-Guaqueta, D.

129 5S p. S161
article
39 AN ATYPICAL PRESENTATION OF FAMILIAL MEDITERRANEAN FEVER Xu, J.

129 5S p. S126-S127
article
40 AN ATYPICAL PRESENTATION OF LIPOPOLYSACCHARIDE-RESPONSIVE BEIGE-LIKE ANCHOR PROTEIN DEFICIENCY Berger, J.

129 5S p. S122-S123
article
41 A NEAR MISS IS AS GOOD AS A MILE: RECOGNIZING HYPEREOSINOPHILIC SYNDROME Chastant, A.

129 5S p. S119-S120
article
42 AN EMR INTERVENTION TO IMPROVE EARLY INTRODUCTION OF PEANUTS IN INFANTS AT COMMUNITY-BASED HEALTH CLINICS Kaur, S.

129 5S p. S62
article
43 AN EPISODE OF ANGIOEDEMA TRIGGERED BY DRY NEEDLING Roper, J.

129 5S p. S113
article
44 A NEWLY DEVELOPED WEB BASED ANAPHYLAXIS CURRICULUM IMPROVES THE EFFECTIVENESS OF UNASSIGNED EPINEPHRINE ADMINISTRATORS Beheshti, R.

129 5S p. S15
article
45 AN INFANT WITH HEREDITARY ALPHA TRYPTASEMIA AND ELEVATED INTESTINAL MAST CELLS IMPROVES WITH CYPROHEPTADINE TREATMENT Elsayed-Ali, O.

129 5S p. S162
article
46 A NOVEL CASE OF DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) AFTER METOLAZONE USE Ayyash, A.

129 5S p. S99
article
47 A NOVEL EFFICIENT APPROACH TO ASSESSING ATOPIC DERMATITIS DISEASE SEVERITY: VIGAXBSA COMPARED TO EASI Loop, L.

129 5S p. S70
article
48 A NOVEL IKBKG MUTATION IDENTIFIED IN A PATIENT WITH RECURRENT SKIN LESION Essink, J.

129 5S p. S143
article
49 A NOVEL MUTATION OF IL21R IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY Huq, M.

129 5S p. S122
article
50 A NOVEL PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT VARIANT IDENTIFIED IN T-B-NK+ SEVERE COMBINED IMMUNODEFICIENCY Underwood, B.

129 5S p. S140-S141
article
51 ANTROCHOANAL POLYP: AN UNCOMMON CAUSE OF CHRONIC NASAL CONGESTION IN PEDIATRIC PATIENTS Herman, K.

129 5S p. S153
article
52 AN UNCOMMON CAUSE OF LIP SWELLING Roth, K.

129 5S p. S117
article
53 AN UNUSUAL CASE OF CHRONIC COUGH IN A PEDIATRIC PATIENT Suyo, M. Mendoza

129 5S p. S160-S161
article
54 AN UNUSUAL CASE OF CHRONIC RHINOSINUSITIS Mollah, F.

129 5S p. S152-S153
article
55 AN UNUSUAL PRESENTATION OF STEVENS-JOHNSON SYNDROME (SJS) IN A PATIENT WITH TWO PRIOR SJS EPISODES Park, K.

129 5S p. S84
article
56 AN UNUSUAL TRANSITION FROM CUTANEOUS TO SYSTEMIC MASTOCYTOSIS IN A PEDIATRIC PATIENT Patel, K.

129 5S p. S156
article
57 A NUTTY CASE: RARE PRESENTATION OF ALLERGIC VAGINITIS Raja, S.

129 5S p. S165
article
58 A PATIENT WITH KABUKI SYNDROME AND HYPOGAMMAGLOBULINEMIA DEVELOPS BURKITT LYMPHOMA Raj, R.

129 5S p. S133
article
59 APPROACHING THE STIFF UPPER LIP: A CASE OF PSEUDOANGIOEDEMA DIAGNOSED AS OROFACIAL GRANULOMATOSIS Viverios, M.

129 5S p. S112-S113
article
60 A RARE CASE OF PROTRACTED ANAPHYLAXIS CAUSED BY ACETAMINOPHEN Newell, P.

129 5S p. S103
article
61 A RARE CAUSE OF URTICARIA IN AN NSAID TOLERANT PATIENT Le, T.

129 5S p. S86
article
62 A RARE MANIFESTATION OF KIDNEY DISEASE IN COMMON VARIABLE IMMUNODEFICIENCY Buckey, T.

129 5S p. S142-S143
article
63 A RED HERRING? PAINFUL URTICARIA FOLLOWING AMPICILLIN CONTACT EXPOSURE Ellingwood, S.

129 5S p. S116
article
64 A REFRACTORY CASE OF HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS Balasubramaniam, D.

129 5S p. S124
article
65 A SEVERE ADVERSE DRUG REACTION (ADR) TO REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) Abou-Jaoude, E.

129 5S p. S101
article
66 ASSOCIATION BETWEEN SMELL LOSS, DISEASE BURDEN, AND DUPILUMAB EFFICACY IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS Soler, Z.

129 5S p. S72
article
67 ASSOCIATION OF GUT DYSBIOSIS AND DEVELOPMENT OF BRONCHIAL ASTHMA AMONG PEDIATRIC PATIENTS: A SYSTEMATIC REVIEW Cua, A.

129 5S p. S79-S80
article
68 ASTHMA EXACERBATIONS BEFORE AND AFTER TEZEPELUMAB TREATMENT: A POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES Mathur, S.

129 5S p. S4
article
69 ASTHMA SEVERITY AND RISK OF ISCHEMIC HEART DISEASE(IHD) Zheng, J.

129 5S p. S3
article
70 ASTHMATIC PATIENTS ARE AT RISK FOR EXACERBATIONS IRRESPECTIVE OF CONTROL, MAINTENANCE ADHERENCE, OR DISEASE SEVERITY Lanz, M.

129 5S p. S47
article
71 A SUCCESSFUL DESENSITIZATION TO OFATUMUMAB Schuldt, M.

129 5S p. S88
article
72 A SUCCESSFUL 4-HOUR ACETYLSALICYLIC ACID DESENSITIZATION PROTOCOL IN AN ATOPIC PATIENT WITH ACUTE CORONARY SYNDROME Ruiz, A. Chávez

129 5S p. S100
article
73 A SYMPATHETIC CASE OF MULTIPLE INHALER INTOLERANCES Ghiasi, Y.

129 5S p. S89
article
74 ASYMPTOMATIC EOSINOPHILIA WITH REACTIVE HYPERGAMMAGLOBULINEMIA Tan, G.

129 5S p. S161
article
75 ATOPIC DERMATITIS IMPACT PATIENT LIVES AS MEASURED WITH WEARABLE DIGITAL TECHNOLOGY Winders, T.

129 5S p. S75
article
76 ATOPIC DERMATITIS IN 86-YEAR-OLD MAN? BETTER THINK TWICE… Rilett, K.

129 5S p. S158
article
77 ATTACK LOCATION AND SEVERITY/RESOLUTION IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE); OBSERVATIONS FROM COMMUNITY IMMUNOLOGY Lumry, W.

129 5S p. S31
article
78 ATTITUDES TOWARDS ORAL IMMUNOTHERAPY AMONG A DIVERSE, FOOD-ALLERGIC POPULATION Thivalapill, N.

129 5S p. S66-S67
article
79 ATYPICAL FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME (FPIES) TO SHELLFISH IN A PEDIATRIC PATIENT Zadoo, S.

129 5S p. S150
article
80 ATYPICAL IPEX SYNDROME PRESENTING AS SEVERE APLASTIC ANEMIA AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS RESPONSIVE TO TACROLIMUS Sidhom, A.

129 5S p. S137
article
81 ATYPICAL PRESENTATION OF X-LINKED IL-2 RECEPTOR GAMMA MUTATION CHARACTERIZED BY RECURRENT CUTANEOUS AND GENITAL WARTS Chin, A.

129 5S p. S135
article
82 A UNIQUE CASE OF ALLERGIC URTICARIA AND ANGIOEDEMA SECONDARY TO ICODEXTRIN Modi, S.

129 5S p. S111
article
83 A UNIQUE CLINICAL PRESENTATION OF COMMON VARIABLE IMMUNODEFICIENCY: MALAKOPLAKIA OF RECTUM. Zidan, E.

129 5S p. S129-S130
article
84 A UNIQUE PRESENTATION OF GATA2 DEFICIENCY, EMBERGER SYNDROME Yamak, O.

129 5S p. S132
article
85 Author Index
129 5S p. S190-S196
article
86 AUTOIMMUNE DISEASE BURDEN IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: A NATIONWIDE LONGITUDINAL STUDY. Jakhar, I.

129 5S p. S65
article
87 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME WITH INITIAL PRESENTATION OF HODGKIN'S LYMPHOMA Fox, E.

129 5S p. S142
article
88 A 5 YEAR-OLD BOY WITH ATYPICAL UPPER LIP SWELLING Jutla, S.

129 5S p. S117
article
89 BACITRACIN ANAPHYLAXIS WITH MUCOSAL BUT NOT CUTANEOUS EXPOSURE Cline, N.

129 5S p. S87
article
90 BALANCING GVHD IMMUNOSUPPRESSION AND COVID19 VIRAL REACTIVATION IN A PATIENT WITH ATYPICAL COMPLETE DIGEORGE SYNDROME Breidenbaugh, M.

129 5S p. S127
article
91 BARRIERS OF USE OF PROMS AMONG ALLERGISTS WHO TREAT ATOPIC DERMATITIS AND CHRONIC URTICARIA Maurer, M.

129 5S p. S33-S34
article
92 BAYESIAN NETWORK ANALYSIS INDICATES A HIGH PROBABILITY OF SIMULTANEOUS SENSITIZATION TO MAJOR GRASS ALLERGENS Rodinkova, V.

129 5S p. S23
article
93 B DISCERNING: ROLE OF RITUXIMAB IN INTERFERON GAMMA AUTOANTIBODY DISEASE Rosenberg, D.

129 5S p. S142
article
94 BIOMARKER LEVELS VARY BY SEX, RACE, AND ETHNICITY AMONG SPECIALIST-TREATED PATIENTS WITH SEVERE ASTHMA Carstens, D.

129 5S p. S46
article
95 BIOMARKERS OF CYTOKINE STORM AND INFLAMMATION IN SEPSIS, POST-COVID-19 PATIENTS AND COVID-19 VACCINATED INDIVIDUALS Titov, L.

129 5S p. S56
article
96 BIPHASIC ALLERGY TO ACETAMINOPHEN: AN ADDITIONAL APPEARANCE IN THE POST-DELIVERY POPULATION Gyaltsen, T.

129 5S p. S106
article
97 BRACHIAL NEURITIS FROM THE MRNA SARS-COV-2 AND INFLUENZA VACCINES VanLancker, J.

129 5S p. S96-S97
article
98 BRIGATINIB INDUCED PHOTOSENSITIVITY Yie, C.

129 5S p. S104
article
99 CANCER RISK WITH TOPICAL PIMECROLIMUS AND TACROLIMUS FOR ATOPIC DERMATITIS: SYSTEMATIC REVIEW AND BAYESIAN META-ANALYSIS Chu, A.

129 5S p. S7
article
100 CANDIDA TROPICALIS FUNGEMIA IN AN ADOLESCENT PATIENT WITH SICKLE CELL DISEASE ON CRIZANLIZUMAB MacMath, D.

129 5S p. S127
article
101 CARD11 MUTATION IN A PATIENT WITH VERY EARLY ONSET IBD AND IMMUNODEFICIENCY Martone, G.

129 5S p. S139-S140
article
102 CASE OF CHRONIC EOSINOPHILIC PNEUMONIA IN A PREGNANT PATIENT Mehra, A.

129 5S p. S120-S121
article
103 CASE REPORT ON THE DIAGNOSTIC CHALLENGE IN PEDIATRIC HEMODIALYSIS PATIENTS: HYPERSENSITIVITY REACTION TO SYNTHETIC MEMBRANES Ruvalcaba, A. Gonzalez

129 5S p. S95
article
104 CASE STUDY OF CONCURRENT ALPHA-1 ANTITRYPSIN DEFICIENCY AND ASTHMA. Ng, S.

129 5S p. S120
article
105 CHALLENGES IN MANAGING THE LATE ADOLESCENT PATIENT ON PALFORZIA Ghoshhajra, M.

129 5S p. S148
article
106 CHARACTERISTICS OF PEDIATRIC PATIENTS WITH IGE-MEDIATED ALLERGY TO GREEN PEA Harrison, H.

129 5S p. S63
article
107 CHARACTERIZATION OF COMMERCIAL DOG ALLERGEN EXTRACTS, INCLUDING NEW ULTRAFILTERED DOG EXTRACT Brown, S.

129 5S p. S22
article
108 CHARACTERIZATION OF PATIENTS WITH ASTHMA INITIATING DUPILUMAB FROM A REAL-WORLD STUDY: THE RAPID REGISTRY Lugogo, N.

129 5S p. S45
article
109 CHARACTERIZATION OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS MANAGED BY GASTROENTEROLOGISTS AND ALLERGISTS: REAL-WORLD CLINICAL PRACTICE EVIDENCE Xu, X.

129 5S p. S78-S79
article
110 CHARACTERIZING ANAPHYLAXIS IN INFANTS PRESENTING TO THE EMERGENCY DEPARTMENT Shannon, C.

129 5S p. S18-S19
article
111 CHARACTERIZING OVERLAPPING RADIOCONTRAST MEDIA, SHELLFISH, AND IODINE ALLERGIES Huang, J.

129 5S p. S17
article
112 CHOOSE YOUR OWN ADVENTURE: AUTOINFLAMMATORY DISEASE, IMMUNODEFICIENCY, AND HIRSCHSPRUNG'S, OH MY! Gabreski, L.

129 5S p. S128
article
113 CHRONIC GRANULOMATOUS DISEASE PRESENTING AS COW'S MILK ALLERGY AND EOSINOPHILIC ESOPHAGITIS Patel, P.

129 5S p. S136
article
114 CHRONIC SPONTANEOUS URTICARIA, LOW HISTAMINE DIET AS A TREATMENT Ricks, A.

129 5S p. S151-S152
article
115 CLINICAL AND ECONOMIC BURDEN OF HERPES ZOSTER IN PATIENTS WITH ASTHMA: A RETROSPECTIVE COHORT STUDY Singer, D.

129 5S p. S43-S44
article
116 CLINICAL ASSESSMENT OF PHARMACOKINETICS AND SAFETY OF NOVEL GLYCINE STABILIZED 10% IVIG IN PIDD PATIENTS Geng, B.

129 5S p. S57-S58
article
117 CLINICAL CHARACTERISTICS, ETIOLOGIES, AND OUTCOMES OF SEVERE EOSINOPHILIA IN PEDIATRIC PATIENTS Ni, M.

129 5S p. S79
article
118 COMMON VARIABLE IMMUNODEFICIENCY WITH UNUSUAL PERIPHERAL NEUROPATHY AND ASSOCIATED IL-7 RECEPTOR MUTATION Baxter, J.

129 5S p. S127
article
119 COMPLETE RESOLUTION OF ACQUIRED ANGIOEDEMA FROM SPLENIC MARGINAL ZONE LYMPHOMA AFTER TREATMENT WITH RITUXIMAB Wang, B.

129 5S p. S110-S111
article
120 CONSISTENTLY LOW HEREDITARY ANGIOEDEMA ATTACK RATES OBSERVED WITH BEROTRALSTAT REGARDLESS OF PREVIOUS PROPHYLAXIS: REAL-WORLD OUTCOMES Riedl, M.

129 5S p. S30
article
121 COVID-19 VACCINE ADMINISTRATION IN PATIENTS WITH FIRST-DOSE ADVERSE REACTIONS OR HISTORY OF SEVERE ALLERGIC REACTION Vanijcharoenkarn, K.

129 5S p. S19-S20
article
122 COVID-19 VACCINE REACTIONS AND SUSPECTED POLYETHYLENE GLYCOL ALLERGY: A PEDIATRIC CASE SERIES Laditan, M.

129 5S p. S17-S18
article
123 CTLA4 VARIANT OF UNCERTAIN SIGNIFICANCE IN A PATIENT WITH A HISTORY OF CYTOPENIAS Scanlon, N.

129 5S p. S145
article
124 CULTURAL COMPETENCY IN FOOD ALLERGY: NEW FROG ALLERGY IN KNOWN FISH ALLERGIC PATIENT Sampognaro, L.

129 5S p. S149
article
125 DANGERS AT THE DINNER TABLE – A REPORT OF ANAPHYLAXIS TO LION'S MANE MUSHROOM Watson, C.

129 5S p. S147
article
126 DATA FROM A MAINTENANCE AND RELIEVER DIGITAL SYSTEM SUPPORT PATIENT–CLINICIAN INTERACTIONS IN ASTHMA Mosnaim, G.

129 5S p. S41
article
127 DECREASING IGG LEVELS IN A PATIENT WITH BRUTON'S AGAMMAGLOBULINEMIA: A CAUSE FOR INVESTIGATION Graneiro, A.

129 5S p. S144
article
128 DELAYED ANAPHYLAXIS TO SHRIMP EXPOSURE: IS THIS A THING, AND WHO IS AT RISK? Geisler, J.

129 5S p. S105
article
129 DELAYED, PERSISTENT ANAPHYLAXIS AFTER AN ALLERGY INJECTION VanLancker, J.

129 5S p. S97
article
130 DELAYED TYPE HYPERSENSITIVITY IN A TRICENARIAN WITH SKIN PRICK TESTING Sutherland, A.

129 5S p. S107
article
131 DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A US-BASED INSURANCE CLAIMS DATA ANALYSIS Xu, X.

129 5S p. S54-S55
article
132 DESENSITIZATION TO EXTENSIVELY HYDROLYZED FORMULA IN INFANT WITH COW'S MILK PROTEIN ALLERGY Jaroenpuntaruk, V.

129 5S p. S148
article
133 DESENSITIZATION TO PROPYLTHIOURACIL WITH SUBSEQUENT LONG-TERM THERAPY TOLERANCE IN A PREGNANT PATIENT Hartono, S.

129 5S p. S104
article
134 DETERIORATION OF RESPIRATORY STATUS IN A CVID PATIENT WITH GLILD AND COVID-19 Kimura, N.

129 5S p. S133
article
135 DEVELOPING AN INFANT ATOPIC DERMATITIS SCORECARD FOR PEDIATRIC CLINICIANS Samady, W.

129 5S p. S75
article
136 DEVELOPMENT OF AN AGE AND CULTURALLY RELEVANT FOOD FREQUENCY QUESTIONNAIRE FOR FOOD ALLERGENS Venter, C.

129 5S p. S65-S66
article
137 DEVELOPMENT OF PHVS719: AN ORAL EXTENDED-RELEASE BRADYKININ B2 RECEPTOR ANTAGONIST TO PREVENT HEREDITARY ANGIOEDEMA ATTACKS Lesage, A.

129 5S p. S31
article
138 DEVELOPMENT OF THE PATIENT-IMPORTANT OUTCOMES NATIONAL DATA REPOSITORY (PIONEER) FOR HEREDITARY ANGIOEDEMA (HAE) Lumry, W.

129 5S p. S30-S31
article
139 DIAGNOSIS AND MANAGEMENT OF CTLA-4 VARIANT IMMUNE DYSREGULATION Ishmael, L.

129 5S p. S128
article
140 DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGIC PATIENTS ACROSS SEVERITY AND ALLERGENS: A NATIONWIDE US SURVEY Ciaccio, C.

129 5S p. S60
article
141 DIAGNOSTIC PARAMETERS OF CAT EXTRACTS FOR SKIN PRICK TESTING AGAINST GOLD STANDARD NASAL PROVOCATION TESTING Brown, S.

129 5S p. S24
article
142 DIAGNOSTIC PATHWAYS IN LANADELUMAB-TREATED PATIENTS WITH NORMAL C1-INHIBITOR HEREDITARY ANGIOEDEMA (NC1-INH-HAE): A MULTICENTER CHART REVIEW Bernstein, J.

129 5S p. S29
article
143 Disclosures
129 5S p. S166-S189
article
144 DISTINGUISHING POLYCYTHEMIA FROM ALLERGIC PRURITUS Capt, B.

129 5S p. S153
article
145 DOES RACE IMPACT THE RELATIONSHIPS BETWEEN FENO AND CLINICAL CHARACTERISTICS OF ASTHMA AND ALLERGIC DISORDERS? Hauk, M.

129 5S p. S37
article
146 DON'T SWEAT IT: A CASE OF PID-LUNG DISEASE MISDIAGNOSED AS CYSTIC FIBROSIS Rotella, K.

129 5S p. S130
article
147 DUPILAMAB FOR POST-VIRAL SMELL LOSS IN ALLERGIC RHINITIS AND CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPOSIS Fernandez, E.

129 5S p. S152
article
148 DUPILUMAB AS A POTENTIAL DISEASE-MODIFYING INTERVENTION FOR CHRONIC SPONTANEOUS URTICARIA: 3-YEAR FOLLOW-UP RESULTS Abadeh, A.

129 5S p. S26
article
149 DUPILUMAB ASSOCIATED DERMATITIS: AN EMERGING ADVERSE EFFECT Chew, W.

129 5S p. S155
article
150 DUPILUMAB EFFICACY IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA BY IGE LEVEL: LIBERTY-CSU CUPID STUDY A Maurer, M.

129 5S p. S11
article
151 DUPILUMAB IMPROVES CHRONIC RHINOSINUSITIS WITH NASAL POLYPS DISEASE OUTCOMES IRRESPECTIVE OF TYPE 2 SIGNATURE DEFINITION Bachert, C.

129 5S p. S72-S73
article
152 DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC ASPECTS OF EOE: POOLED RESULTS FROM PHASE 3 LIBERTY-EOE-TREET Dellon, E.

129 5S p. S25-S34
article
153 DUPILUMAB INDUCED HYPEREOSINOPHILIC SYNDROME (HES) Abulhamail, A.

129 5S p. S90-S91
article
154 DUPILUMAB REBALANCES IMMUNE RESPONSE IN PEDIATRIC TYPE-2 DISORDERS: IMPACTS ON T-CELL CLONES AND FUNCTIONALITY Geng, B.

129 5S p. S56
article
155 EARLY CHILDHOOD ATOPIC PHENOTYPES AND THE DEVELOPMENT OF ALLERGIC RESPIRATORY DISEASE Ishak, R.

129 5S p. S73
article
156 EARLY DETECTION OF X-LINKED MOESIN-ASSOCIATED IMMUNE DEFICIENCY ON NEWBORN SCREENING Latshaw, S.

129 5S p. S130
article
157 EFFECTIVENESS OF A MAINTENANCE AND RELIEVER DIGITAL SYSTEM TO IMPROVE ASTHMA CONTROL Mosnaim, G.

129 5S p. S40-S41
article
158 EFFECT OF OMALIZUMAB ON VENOM SPECIFIC IGE AND VENOM SKIN TESTING Brooks, R.

129 5S p. S106
article
159 EFFECT OF SEX ON RESPONSE TO OMALIZUMAB IN PATIENTS WITH ASTHMA Holweg, C.

129 5S p. S38-S39
article
160 EFFECT OF TEZEPELUMAB ON ASTHMA INFLAMMATORY BIOMARKER LEVELS VARIES BY BASELINE BIOMARKER LEVELS Corren, J.

129 5S p. S36
article
161 EFFECTS OF ALBUTEROL-BUDESONIDE ON ASTHMA DETERIORATIONS AND SEVERE EXACERBATIONS IN MILD-TO-MODERATE ASTHMA: DENALI EXPLORATORY ENDPOINTS Chipps, B.

129 5S p. S12
article
162 EFFICACY OF BIOLOGICS IN PATIENTS WITH SEVERE ALLERGIC ASTHMA, OVERALL AND BY BLOOD EOSINOPHIL COUNT Bernstein, J.

129 5S p. S3
article
163 EFFICACY OF CONCURRENT TREATMENT WITH OMALIZUMAB IN A PATIENT WITH ANAPHYLAXIS TO VENOM IMMUNOTHERAPY Alnabulsi, R.

129 5S p. S107
article
164 EFFICACY OF DUPILUMAB IN INFANTS AND PRESCHOOLERS WITH ATOPIC DERMATITIS UP TO 1 YEAR Paller, A.

129 5S p. S74
article
165 EFFICACY OF HOUSE DUST MITE IMMUNOTHERAPY IN PATIENTS WITH ATOPIC AND CONTACT DERMATITIS OVERLAP SYNDROME Litus, O.

129 5S p. S7-S8
article
166 EFFICACY OF PINE NUT-SPECIFIC IGE TESTING PRIOR TO ORAL FOOD CHALLENGE Stenehjem, K.

129 5S p. S63
article
167 EFFICACY OF TEZEPELUMAB IN HISPANIC OR LATINO PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA Hill, J.

129 5S p. S35-S36
article
168 EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND HIGH BASELINE BLOOD EOSINOPHIL COUNTS Jain, N.

129 5S p. S36-S37
article
169 EGG ALLERGY AND YELLOW FEVER IMMUNIZATION: A SAFE DESENSITIZATION PLAN Zamora-Sifuentes, J.

129 5S p. S96
article
170 EGPA: A DIAGNOSTIC DILEMMA Ganju, A.

129 5S p. S119
article
171 EHLERS-DANLOS SYNDROME IS ASSOCIATED WITH MAST CELL ACTIVATION SYNDROME AND CHRONIC URTICARIA Walsh, M.

129 5S p. S34
article
172 ELEVATED BASELINE SERUM TRYPTASE AND HEREDITARY ALPHA TRYPTASEMIA (HAT) Fowler, S.

129 5S p. S146-S147
article
173 ELEVATED HISTAMINE LEVELS WITH NORMAL TRYPTASE IN ANAPHYLAXIS Khan, M.

129 5S p. S109
article
174 ENDOVASCULAR STENT PLACEMENT IN A PATIENT WITH NICKEL ALLERGY Browning, R.

129 5S p. S164-S165
article
175 ENVIRONMENTAL FACTORS INFLUENCING SYMPTOMS AND USE OF RELIEF MEDICATIONS IN SUBJECTS WITH SEASONAL ALLERGIC RHINOCONJUNCTIVITIS Zwingers, T.

129 5S p. S24
article
176 EOSINOPHILIC CYSTITIS AS THE FIRST MANIFESTATION OF HYPEREOSINOPHILIC SYNDROME Makol, R.

129 5S p. S108
article
177 EOSINOPHILIC CYSTITIS IN A PEDIATRIC PATIENT WITH X-LINKED CHRONIC GRANULOMATOUS DISEASE Jung, J.

129 5S p. S131
article
178 EOSINOPHILIC MYENTERIC GANGLIONITIS: A RARE CAUSE OF GASTROINTESTINAL DYSMOTILITY D'Silva, N.

129 5S p. S147
article
179 EPINEPHRINE AUTOINJECTOR UTILIZATION AND ACCESS IN A NATIONALLY REPRESENTATIVE FOOD-ALLERGIC ADULT SAMPLE Yost, J.

129 5S p. S7
article
180 EPINEPHRINE NASAL SPRAY (ARS-1) AND INTRAMUSCULAR INJECTION: PHARMACOKINETIC/PHARMACODYNAMIC DIFFERENCES AND DIFFERENTIAL AFFINITIES FOR ADRENERGIC RECEPTORS Kaliner, M.

129 5S p. S76
article
181 EPINEPHRINE VIA NEEDLE-FREE DEVICE WOULD BE ADMINISTERED FASTER AFTER SYMPTOMS: RESULTS OF A PATIENT/CAREGIVER SURVEY Kaplan, H.

129 5S p. S17
article
182 EPITOPE STUDY RESULTS: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF EPICUTANEOUS IMMUNOTHERAPY IN PEANUT-ALLERGIC TODDLERS Burks, A.

129 5S p. S12
article
183 ERYTHRODERMA AND EOSINOPHILIA WITH MULTI-SYSTEM INVOLVEMENT, A CASE OF VRESS Song, C.

129 5S p. S154
article
184 EVALUATION AND MANAGEMENT OF DELAYED HYPERSENSITIVITY REACTION TO INSULIN IN Afshan, T.

129 5S p. S100-S101
article
185 EVALUATION OF GLUTAMATE DECARBOXYLASE (GAD65)-REACTIVE T-CELLS IN PATIENTS WITH NEW-ONSET TYPE 1 DIABETES Minich, Y.

129 5S p. S55
article
186 EXPLORING PARENTAL INTEREST IN IDENTIFYING THE ELICITING DOSE OF PEANUT FOR THEIR PEANUT ALLERGIC CHILD Biswas, L.

129 5S p. S63-S64
article
187 FACIAL CONTACT DERMATITIS CAUSED BY PENCIL ERASERS Eshet, S.

129 5S p. S153-S154
article
188 FACIAL SWELLING, RESPIRATORY FAILURE, FLUCTUATING COMPLEMENT 4 LEVELS, AND RELIGIOUS CONSIDERATION IN A PEDIATRIC PATIENT Kang, A.

129 5S p. S109-S110
article
189 FACTORS INFLUENCING SERUM IGE VARIABILITY AND SECONDARY IGE DEFICIENCY Aouthmany, A.

129 5S p. S54
article
190 FD&C YELLOW #6 HYPERSENSITIVITY UNVEILED IN A PATIENT TREATED WITH CHLORAPREP™ HI-LITE ORANGE Chastant, A.

129 5S p. S102
article
191 FIVE INTERFERON RECEPTOR TRIPLICATES: A UNIQUE CASE OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A DOWN SYNDROME PATIENT Agress, A.

129 5S p. S128
article
192 FIXED DRUG ERUPTION SECONDARY TO FLUCONAZOLE CONFIRMED BY SELF-CHALLENGE Mueller, K.

129 5S p. S91
article
193 FOOD ALLERGEN IMMUNOTHERAPY IS ASSOCIATED WITH A POSITIVE IMPACT ON PATIENT/CAREGIVER-REPORTED WELL-BEING AND SOCIAL INCLUSION Crockett, C.

129 5S p. S61-S62
article
194 FREEDOM FROM ITCH AND HIVES IN CHRONIC SPONTANEOUS URTICARIA IS ASSOCIATED WITH IMPROVED QUALITY-OF-LIFE MEASURES Bernstein, J.

129 5S p. S30
article
195 FROM CVID TO AERD: ADDRESSING EPITHELIAL BARRIER DYSFUNCTION FROM NON-TYPE-2 TO HIGH-TYPE-2 AIRWAY INFLAMMATION Loop, L.

129 5S p. S121
article
196 FROM RASH TO RASH: REGIONAL DERMATOSIS IN PATIENTS ON DUPILUMAB THERAPY Kapoor, M.

129 5S p. S89-S90
article
197 FUNGUS AMONG US? THE ASSOCIATION BETWEEN FUNGAL DERMATOPHYTES AND ALLERGIC HYPERSENSITIVITY REACTIONS Treadwell, S.

129 5S p. S22
article
198 GAPS IN CLINICAL CARE ESCALATION AMONG SEVERE, PERSISTENT ASTHMA PATIENTS FOLLOWING INDICATORS OF UNCONTROLLED ASTHMA Carr, T.

129 5S p. S35
article
199 GASTROINTESTINAL SYMPTOMS WITH ASPIRIN-EXACERBATED RESPIRATORY DISEASE MAY INCREASE RISK FOR FAILURE DURING RAPID ASPIRIN DESENSITIZATION Canty, E.

129 5S p. S16
article
200 GENETICALLY CONFIRMED TYPE I LEUKOCYTE ADHESION DEFICIENCY IN A TWO-YEAR-OLD MALE Edwards-Salmon, S.

129 5S p. S137
article
201 GRADED CHALLENGES TO PENICILLIN IN ICU PATIENTS Nair, L. G

129 5S p. S18
article
202 HEALTHCARE RESOURCE UTILIZATION AMONG LANADELUMAB AND SUBCUTANEOUS C1-INHIBITOR CONCENTRATE NEW USERS - RETROSPECTIVE DATABASE STUDY Riedl, M.

129 5S p. S28-S29
article
203 HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND CAREGIVER PROXIES FROM TRIALS OF PEANUT ORAL IMMUNOTHERAPY Wang, J.

129 5S p. S12-S13
article
204 HEREDITARY ALPHA TRYPTASEMIA MASKED AS ASTHMA EXACERBATION Leudders, J.

129 5S p. S93
article
205 H1 HISTAMINE RECEPTOR SPECIFIC AGONISTS DIFFERENTIALLY MODIFIES TH1/TH2 CYTOKINE SYNTHESIS BY MONONUCLEAR AND DENDRITIC CELLS Khanferyan, R.

129 5S p. S56-S57
article
206 HLA-A*32:01 ASSOCIATED VANCOMYCIN-INDUCED DRESS SYNDROME AND DESQUAMATION IN AN AFRICAN AMERICAN WOMAN Jalali, J.

129 5S p. S88
article
207 HOME MONITORING & TELEHEALTH EDUCATION FOR ASTHMA DISEASE MANAGEMENT Gardner, D.

129 5S p. S48
article
208 HOURLY VARIATION OF POLLEN COUNTS Fineman, S.

129 5S p. S23
article
209 HOW ALLERGISTS ARE SAVING MARRIAGES: A REVIEW ON SEXUAL INTERCOURSE PRESENTING AS EXERCISE-INDUCED ASTHMA Leung, A.

129 5S p. S48
article
210 HYMENOPTERA VENOM SKIN TESTING: ADOPTING AN ACCELERATED TEST METHOD Wang, Q.

129 5S p. S23-S24
article
211 HYPEREOSINOPHILIA LEADS TO PRIMARY IMMUNODEFICIENCY DIAGNOSIS Nguyen, L.

129 5S p. S130
article
212 HYPERSENSITIVITY REACTION TO DUST MITE IMMUNOTHERAPY FOLLOWING SHELLFISH INGESTION Krishna, V.

129 5S p. S106-S107
article
213 HYPERSENSITIVITY TO HUMAN SEMINAL PLASMA IN A TRANSGENDER MALE Lee, J.

129 5S p. S162
article
214 HYPOGAMMAGLOBULINEMIA AS A PRESENTING FINDING OF DGAT1 DEFICIENCY Matrana, D.

129 5S p. S138
article
215 IDIOPATHIC ANAPHYLAXIS: A DIAGNOSTIC CHALLENGE Kalanadhabhatta, V.

129 5S p. S106
article
216 IDIOPATHIC HYPEREOSINOPHILIC SYNDROME DIAGNOSED IN AN INFANT: A CASE REPORT Kwiatkowski, V.

129 5S p. S124-S125
article
217 IF AT FIRST YOU DON'T SUCCEED, TRY TRY AGAIN! Sheth, D.

129 5S p. S120
article
218 IMMUNE RESPONSES IN PATIENTS WITH IGE DEPENDENT AND IGE INDEPENDENT DUST MITE ALLERGIC RHINITIS Yuriev, S.

129 5S p. S73
article
219 IMMUNIZATION STRESS-RELATED RESPONSES DURING SKIN TESTING AND CHALLENGE TO COVID-19 VACCINES: A CASE SERIES Jin, H.

129 5S p. S20
article
220 IMMUNOLOGICAL CHANGES IN NEWBORN EXPOSED TO ANTI-TNF-A, A PERSPECTIVE. Salazar, P.

129 5S p. S121
article
221 IMMUNOMODULATORY MECHANISMS OF GRASS ALLERGEN IMMUNOTHERAPY ON DIFFERENTIAL T CELLS TRANSCRIPTOME POLARIZATION IN EXPLORATORY TRIAL Starchenka, S.

129 5S p. S24-S25
article
222 IMPACT OF ACCESS TO ALLERGEN-FREE FOOD OPTIONS THROUGH WIC ON FOOD ALLERGY-RELATED QUALITY OF LIFE Frame, A.

129 5S p. S64
article
223 IMPACT OF ALLERGEN SENSITIZATION ON AIRFLOW LIMITATION IN CHILDREN WITH SEVERE ASTHMA Boyd, K.

129 5S p. S4
article
224 IMPACT OF EARLY BAKED EGG CHALLENGE ON LIFE QUALITY IN EGG-ALLERGIC PATIENTS VERSUS EGG AVOIDANCE Maini, N.

129 5S p. S61
article
225 IMPACT OF EARLY PEANUT INTRODUCTION GUIDELINES ON INFANT TREE NUT ALLERGY TESTING Huang, P.

129 5S p. S64
article
226 IMPACT OF HEREDITARY ANGIOEDEMA (HAE) ATTACKS ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING Busse, P.

129 5S p. S26
article
227 IMPACT OF INTRODUCING SUBGROUPS OF TREE NUTS VERSUS COMPLETE AVOIDANCE ON QUALITY OF LIFE Benipal, J.

129 5S p. S59
article
228 IMPACT OF TELEHEALTH VISITS ON OUTCOMES AMONG BLACK AND LATINX PATIENTS WITH MODERATE-SEVERE ASTHMA Ugalde, I.

129 5S p. S51-S52
article
229 IMPLEMENTING A REFERRAL PROTOCOL FOR PENICILLIN ALLERGY TESTING OF PREGNANT WOMEN Patel, M.

129 5S p. S70-S71
article
230 IMPLEMENTING THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ®) AND ASTHMA CHECKLIST INTO DIVERSE CLINICAL PRACTICES Yawn, B.

129 5S p. S50-S51
article
231 IMPROVEMENT OF SEVERE ATOPIC DERMATITIS AND POST-INFLAMMATORY HYPERPIGMENTATION IN A HISPANIC PATIENT TREATED WITH DUPILUMAB Guzmán, T. Delgado

129 5S p. S155-S156
article
232 IMPROVEMENTS IN SELECT PATIENT-REPORTED OUTCOMES ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS Chase, N.

129 5S p. S39
article
233 INCIDENCE OF COVID-19 INFECTIONS IN ADULTS WITH PRIMARY IMMUNODEFICIENCY AFTER RECEIVING TIXAGEVIMAB AND CILGAVIMAB Johnson, S.

129 5S p. S54
article
234 INCREASED EOSINOPHIL GRANULE PROTEIN PRODUCTION IN CHRONIC SPONTANEOUS URTICARIA Khanna, S.

129 5S p. S33
article
235 INCREASING THE PERCENTAGE OF PATIENTS THAT RECEIVE THE INFLUENZA VACCINE IN ALLERGY SHOT CLINICS Flettrich, L.

129 5S p. S25
article
236 INDOLENT SYSTEMIC MASTOCYTOSIS PRESENTING AS AN EXCIPIENT ALLERGY Franzblau, L.

129 5S p. S96
article
237 INFANTILE AGGRESSIVE SYSTEMIC MASTOCYTOSIS TREATED WITH ORAL MIDOSTAURIN Krase, I.

129 5S p. S91
article
238 INHALER TECHNIQUE MAINTENANCE IN PATIENTS WITH UNCONTROLLED ASTHMA USING A RELIEVER DIGITAL SYSTEM Hoyte, F.

129 5S p. S41-S42
article
239 INNOVATIVE COMPOUNDS TO REDUCE SS-D-GLUCANS, ENDOTOXIN, AND ALLERGENS NEWLY DISCOVERED ON SMARTPHONES Ruran, H.

129 5S p. S21-S22
article
240 INTESTINAL LYMPHANGIECTASIA AS A SECONDARY CAUSE OF ABNORMAL TREC SCREEN Robertson, G.

129 5S p. S139
article
241 IN VIVO CRISPR/CAS9 EDITING OF KLKB1 IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A FIRST-IN-HUMAN STUDY Longhurst, H.

129 5S p. S10-S11
article
242 IS IT A HERXHEIMER REACTION OR ANAPHYLAXIS COMPLICATING USE OF PENICILLIN IN SYPHILIS TREATMENT? Yeich, A.

129 5S p. S83
article
243 IS PEA OUR HIDDEN ALLERGEN? AN AMERICAN PEDIATRIC CASE SERIES Melhem, R. Abi

129 5S p. S147-S148
article
244 ITCHING TO GO TO THE DENTIST Mohyi, P.

129 5S p. S114
article
245 KNOWLEDGE OF ANAPHYLAXIS MANAGEMENT AMONG LATIN AMERICAN DENTISTS Bastidas, J. Gallardo

129 5S p. S20
article
246 KOUNIS SYNDROME, THE ALLERGIC HEART ATTACK Moussa, R.

129 5S p. S83
article
247 LANGERHANS CELL HISTIOCYTOSIS IN A CHILD WITH ALBINISM AND INVASIVE SKULL LESIONS Nguyen, M.

129 5S p. S140
article
248 LATE-ONSET COMBINED IMMUNE DEFICIENCY IN A PATIENT WITH ADENOSINE DEAMINASE GENE MUTATION Pickett, G.

129 5S p. S123
article
249 LATE ONSET IPEX SYNDROME IN AN ADOLESCENT MALE Sullivan, S.

129 5S p. S131
article
250 LIABILITY: A MISUNDERSTOOD BARRIER TO STOCK ALBUTEROL IMPLEMENTATION IN ILLINOIS SCHOOLS Wrona, J.

129 5S p. S39-S40
article
251 LIKE FATHER, LIKE SON: HEREDITARY ANGIOEDEMA (HAE) WITH LOW C1Q LEVELS Suresh, R.

129 5S p. S113
article
252 LIKELIHOOD OF DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS VIA ENDOSCOPY IN DYSPHAGIA DURING THE COVID-19 PANDEMIC Brennan, J.

129 5S p. S25
article
253 LIMB LENGTH ANOMALIES ON PRENATAL ULTRASOUND; A DIAGNOSTIC CLUE FOR CARTILAGE HAIR HYPOPLASIA Hanau, J.

129 5S p. S138
article
254 LIMITED CUTANEOUS SYSTEMIC SCLEROSIS MIMICKING HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR Liao, J.

129 5S p. S115-S116
article
255 LONG-TERM DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN TYPE 2 PATIENTS WITH/WITHOUT ALLERGIC Sher, L.

129 5S p. S44-S45
article
256 LONG-TERM EFFICACY, SAFETY, AND QUALITY OF LIFE WITH LANADELUMAB TREATMENT IN ADOLESCENTS WITH HEREDITARY ANGIOEDEMA Craig, T.

129 5S p. S28
article
257 LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA: LIBERTY ASTHMA EXCURSION Bacharier, L.

129 5S p. S44
article
258 LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH DUPILUMAB UP TO 4 YEARS Blauvelt, A.

129 5S p. S19
article
259 MAKING A STAT DIAGNOSIS IN A PATIENT PRESENTING WITH VILLOUS ATROPHY Dages, K.

129 5S p. S126
article
260 MALIGNANCY MASQUERADING AS STEROID RESISTANT HYPEREOSINOPHILIA SYNDROME Parashar, S.

129 5S p. S135
article
261 MANUFACTURING PROCESSES AND STANDARDIZATION OF ALLERGEN POTENCY OF PEANUT (ARACHIS HYPOGAEA) ALLERGEN POWDER-DNFP Tilles, S.

129 5S p. S59
article
262 MAST CELL ACTIVATION SYNDROME AND ANTI -IMMUNOGLOBULIN E THERAPY FOR THERAPY-RESISTANT MCAS Nsouli, T.

129 5S p. S117
article
263 MAST CELL LEUKEMIA: A CASE REPORT Ender, E.

129 5S p. S164
article
264 MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON BETWEEN LANADELUMAB AND BEROTRALSTAT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS Watt, M.

129 5S p. S26
article
265 MEANINGFUL RESPONSES IN TRALOKINUMAB-TREATED ADOLESCENTS WITH ATOPIC DERMATITIS NOT ACHIEVING IGA 0/1 AT WEEK-16 Paller, A.

129 5S p. S74
article
266 METHOTREXATE TREATMENT FOR SEVERE ATOPIC DERMATITIS PATIENTS WITH PERSISTENT KERATOCONJUNCTIVITIS ASSOCIATED WITH DUPILUMAB Ziaie, N.

129 5S p. S154
article
267 MINIMAL IMPACT OF FOOD, DRINK, OR TEMPERATURE ON THE PHARMACOKINETICS OF A SUBLINGUAL FILM USING AA NOVEL PRODRUG OF EPINEPHRINE (DESF) Slatko, G.

129 5S p. S21
article
268 MODELING AND SIMULATION PREDICTS ROBUST HAE ATTACK SUPPRESSION WITH EVERY 3 MONTH DOSING OF STAR-0215 Chung, J.

129 5S p. S33
article
269 MODELLING OF ZAP-70 ACTIVATION UPON PHOSPHORYLATION OF TYR315, TYR319 AND TYR493 FOR SIGNALLING T-CELL ACTIVATION Urban, V.

129 5S p. S55
article
270 MOMMY RN DERMATITIS Majid, S.

129 5S p. S158
article
271 MORE THAN JUST A “RUNNY NOSE”: A COMBINATION OF VASOMOTOR RHINITIS AND CEREBROSPINAL FLUID LEAK Cronin, K.

129 5S p. S152
article
272 MRNA COVID-19 VACCINE-ASSOCIATED BULLOUS FIXED DRUG ERUPTION Imam, S.

129 5S p. S93-S94
article
273 MULTIFOCAL FIXED DRUG ERUPTION IN AN ATOPIC PATIENT Alluri, S.

129 5S p. S157
article
274 MUSCLE TENSION DYSPHONIA MASQUERADING AS ASTHMA Imam, K.

129 5S p. S118-S119
article
275 MYCOSIS FUNGOIDES (MF): THE MASTER OF MIMICRY Bakar, D.

129 5S p. S158-S159
article
276 NON-CLINICAL SAFETY EVALUATION OF A NOVEL THERAPEUTIC VACCINE FOR PEANUT ALLERGY Kirk, S.

129 5S p. S61
article
277 NON-INFECTIOUS COMPLICATIONS AFFECT SURVIVAL IN CVID PATIENTS D'Netto, M.

129 5S p. S5
article
278 NOT ALL RASHES ASSOCIATED WITH INFANT FEEDING ARE FROM COW MILK PROTEIN ALLERGY! Nomula, K.

129 5S p. S150-S151
article
279 NOVEL HETEROZYGOTE MUTATION OF LRBA ASSOCIATED WITH CVID Sewell, C.

129 5S p. S122
article
280 NOVEL HETEROZYGOUS SINGLE NUCLEOTIDE POLYMORPHISM IN STAT-3 GENE IN PATIENT WITH SUSPECTED HYPER IGE SYNDROME Keskin, S.

129 5S p. S146
article
281 NOVEL PLANT-BASED PEDIATRIC FORMULA ALTERNATIVE FOR MANAGEMENT OF NON-IGE-MEDIATED FOOD ALLERGIES: A CASE STUDY Bair, E.

129 5S p. S151
article
282 OBJECTIVE MEASUREMENT OF ADHERENCE TO ASTHMA TREATMENT WITH A MAINTENANCE AND RELIEVER DIGITAL SYSTEM Mosnaim, G.

129 5S p. S42
article
283 OCULAR SURFACE DISEASE ALLEVIATED WITH DUPILUMAB: A CASE SERIES Chen, J.

129 5S p. S80-S81
article
284 OMALIZUMAB: A POTENTIAL LONG-TERM THERAPEUTIC ALTERNATIVE FOR REFRACTORY DELAYED PRESSURE URTICARIA? Jaroenpuntaruk, V.

129 5S p. S109
article
285 OMALIZUMAB FOR SKEETER SYNDROME: THREE SUCCESSFULLY TREATED PATIENTS Zelig, A.

129 5S p. S101-S102
article
286 OMALIZUMAB TREATMENT OF CHRONIC SPONTANEOUS URTICARIA: EFFECTIVENESS AND SATISFACTION ASSESSED BY A REAL-WORLD SURVEY Casale, T.

129 5S p. S27
article
287 ONSET OF ACTION OF AZELASTINE HCL NASAL SPRAY 0.15% EVALUATED IN AN ENVIRONMENTAL EXPOSURE CHAMBER Hsu, S.

129 5S p. S71
article
288 OPEN-LABEL SAFETY TRIAL OF HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN ADOLESCENTS WITH ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS Nolte, H.

129 5S p. S24
article
289 ORAL FOOD CHALLENGE OUTCOMES AT 1 YEAR, 2 YEARS, AND 3 YEARS OF ORAL IMMUNOTHERAPY Nguyen, K.

129 5S p. S67
article
290 ORAL GLUTAMINE SUPPLEMENTATION FOR REFRACTORY ECZEMA AND ERYTHRODERMA WITH A HYPER-IGE PHENOTYPE Wilson, B.

129 5S p. S156
article
291 ORAL IMMUNOTHERAPY IN CHILDREN WITH PEANUT ALLERGY ALONE OR WITH OTHER FOOD ALLERGY IN PALISADE Toit, G. Du

129 5S p. S59-S60
article
292 ORAL LICHENOID DRUG ERUPTION SECONDARY TO RITUXIMAB ADMINISTRATION Wautlet, A.

129 5S p. S89
article
293 ORAL WARTS IN A PEDIATRIC PATIENT WITH TRISOMY 21 SUCCESSFULLY TREATED WITH HUMAN PAPILLOMAVIRUS VACCINE Grohman, R.

129 5S p. S141
article
294 OUTCOMES AND IMPACT OF COVID-19 ON INFECTION DIAGNOSIS RATES AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES Riaz, F.

129 5S p. S52
article
295 OUTCOMES OF SINGLE BAG PROTOCOLS FOR DESENSITIZATION TO ANTINEOPLASTIC AGENTS Raley, E.

129 5S p. S105
article
296 PAINFUL SKIN LESIONS AFTER STARTING SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT Choi, P.

129 5S p. S105
article
297 PAINLESS HERPES ZOSTER IN THE SETTING OF EOSINOPHILIA AND MARKEDLY ELEVATED IGE LEVELS Patel, A.

129 5S p. S86
article
298 PARANOID ABOUT RASHES: OLANZAPINE INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS Knight, S.

129 5S p. S93
article
299 PARENT-REPORTED OUTCOMES DESIGN IN A DIGITAL EARLY ALLERGEN FEEDING STUDY WITH ECZEMATOUS AND NON-ECZEMATOUS INFANTS Swanson, W.

129 5S p. S67-S68
article
300 PATIENT AND CAREGIVER PERSPECTIVES ON TREATMENT WITH LICENCED PEANUT ALLERGY ORAL IMMUNOTHERAPY IN PRACTICE Forster, K.

129 5S p. S58-S59
article
301 PATIENT AND CLINICIAN PREFERENCES WITH BIOLOGIC TREATMENTS FOR SEVERE ASTHMA: A DISCRETE CHOICE EXPERIMENT Chung, Y.

129 5S p. S50
article
302 PATIENT CHARACTERISTICS AND RESPONSE TO BIOLOGIC THERAPIES IN MODERATE-TO-SEVERE PEDIATRIC ASTHMA Abernathy, S.

129 5S p. S51
article
303 PATIENT PERCEPTION OF THE ROLE OF THE ALLERGIST IN THE PRIMARY CARE SETTING Abou-Jaoude, E.

129 5S p. S69-S70
article
304 PATIENT-REPORTED EXPERIENCE OF EOSINOPHIL-DRIVEN DISEASES ON ONLINE PLATFORMS: SOCIAL LISTENING ANALYSIS INSIGHTS Strobel, M.

129 5S p. S52
article
305 PATIENT-REPORTED SYMPTOMS, IMPACTS, AND TREATMENT PREFERENCES IN REFRACTORY OR UNEXPLAINED CHRONIC COUGH: A QUALITATIVE STUDY Bali, V.

129 5S p. S77
article
306 PATIENT-REPORTED SYMPTOMS OF EOSINOPHILIC ESOPHAGITIS IN THE UNITED STATES: EVIDENCE FROM REAL-WORLD CLINICAL PRACTICE Xu, X.

129 5S p. S78
article
307 PATIENT-REPORTED TRIGGER NUMBER IS A STRONG PREDICTOR OF UNCONTROLLED DISEASE AMONG PATIENTS WITH SEVERE ASTHMA Chipps, B.

129 5S p. S46-S47
article
308 PATIENTS’ PERSPECTIVE ON THE BURDEN OF HYPEREOSINOPHILIC SYNDROME Silver, J.

129 5S p. S80
article
309 PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB Mosnaim, G.

129 5S p. S10
article
310 PEANUT COMPONENT TESTING: NOT THE ONLY COMPONENT Penna, G. Della

129 5S p. S149-S150
article
311 PEDIATRIC ANAPHYLAXIS TO PIPERACILLIN-TAZOBACTAM REQUIRES FURTHER ALLERGY TESTING TO OTHER PENICILLINS DUE TO SELECTIVE SENSITIZATION. Arceri, T.

129 5S p. S95-S96
article
312 PEDIATRIC LEIGH SYNDROME: EVIDENCE OF IMMUNE DYSFUNCTION AND SUCCESSFUL TREATMENT WITH IMMUNOGLOBULIN REPLACEMENT Zadoo, S.

129 5S p. S143
article
313 PENICILLIN ALLERGY DELABELLING IN A PEDIATRIC PRIMARY CARE SETTING Patel, G.

129 5S p. S17
article
314 PERSISTENT ANGIOEDEMA AFTER COVID-19 VACCINATION: IS BRADYKININ TO BLAME? Edland, G.

129 5S p. S112
article
315 PERSISTENTLY ELEVATED BASELINE TRYPTASE - A CASE OF HEREDITARY ALPHA TRYPTASEMIA Khan, A.

129 5S p. S163
article
316 PHARMACOKINETICS AND PHARMACODYNAMICS OF ARS-1 AND MANUAL INTRAMUSCULAR INJECTION IN SUBJECTS WITH/WITHOUT ALLERGIC RHINITIS Lowenthal, R.

129 5S p. S76
article
317 PHARMACOKINETICS OF PHVS719, EXTENDED-RELEASE TABLET FORMULATION OF PHA121, A FIRST-IN-CLASS ORAL HUMAN BRADYKININ B2-RECEPTOR ANTAGONIST Groen, K.

129 5S p. S32-S33
article
318 PHARMACOKINETICS/PHARMACODYNAMICS AFTER SINGLE AND REPEAT ADMINISTRATION OF ARS-1, EPINEPHRINE AUTO-INJECTOR, AND MANUAL INTRAMUSCULAR INJECTION Tanimoto, S.

129 5S p. S76-S77
article
319 PHARMACOKINETICS STUDY OF EPINEPHRINE SUBLINGUAL FILM: RESULTS FROM THE FORMULATION AND DOSAGE SELECTION Freedman, M.

129 5S p. S10
article
320 PHASE 2 OPEN-LABEL EXTENSION STUDY WITH DONIDALORSEN TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA Bordone, L.

129 5S p. S33
article
321 PHYSICIAN AND PATIENT REPORTED OUTCOMES BY HEREDITARY ANGIOEDEMA TYPE: DATA FROM A REAL-WORLD STUDY Anderson, J.

129 5S p. S27-S28
article
322 PIK3CD, IMMUNODEFICIENCY, MUTATIONS, GAIN-OF-FUNCTION Lara, E.

129 5S p. S146
article
323 PILI NUT ANAPHYLAXIS Shah, A.

129 5S p. S149
article
324 PILOT STUDY OF MODIFIED ROTATING ARM IMPACTOR FOR USE IN AEROBIOLOGICAL STUDIES Chen, J.

129 5S p. S22-S23
article
325 POLLEN INDUCED ANAPYLAXIS THROUGH SKIN ABRASION Abulhamail, A.

129 5S p. S83-S84
article
326 POLYMYALGIA RHEUMATICA AFTER MRNA COVID-19 VACCINATION Trotto, N.

129 5S p. S102
article
327 POOLED SAFETY ANALYSIS OF LEBRIKIZUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA FROM THREE RANDOMIZED CLINICAL TRIALS Corren, J.

129 5S p. S34-S35
article
328 POSSIBLE ANAPHYLAXIS TO ASPIRIN IN A PEDIATRIC PATIENT Sacta, M.

129 5S p. S87
article
329 POST COVID RECURRENT FEVER IN A CHILD WITH GENETIC SUSCEPTIBILITY TO FAMILIAL MEDITERRANEAN FEVER Keller, L.

129 5S p. S160
article
330 POSTSURGICAL ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS: TIMING IS EVERYTHING Estrada-Mendizabal, R.

129 5S p. S92
article
331 POST THYMECTOMY: AN EXAMPLE OF IMMUNE DYSREGULATION? Sosa-Castellanos, N.

129 5S p. S145
article
332 PRELIMINARY RETROSPECTIVE ANALYSIS OF PATIENT OUTCOMES ASSOCIATED WITH SUBCUTANEOUS C1INH PROPHYLAXIS FOR HEREDITARY ANGIOEDEMA Bernstein, J.

129 5S p. S29-S30
article
333 PREMEDICATION REGIMEN FOR THE PREVENTION OF ADVERSE REACTIONS ASSOCIATED WITH THERAPEUTIC PLASMA EXCHANGE Lairet, S.

129 5S p. S100
article
334 PRE-TEEN FATAL COW'S MILK ANAPHYLAXIS: PROTEIN BEVERAGE INGESTION IRREVERSIBLY MISTAKEN WITHOUT ALLERGEN ON FRONT LABEL Spier, H.

129 5S p. S150
article
335 PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION Rosenblum, J.

129 5S p. S19
article
336 PREVALENCE AND ASSOCIATIONS BETWEEN METABOLICALLY UNHEALTHY OBESITY AND ASTHMA EXACERBATIONS AND EMERGENCY DEPARTMENT USAGE Greiner, B.

129 5S p. S49-S50
article
337 PREVALENCE AND BURDEN OF CHRONIC COUGH IN CHINA: RESULTS FROM A POPULATION-BASED SURVEY Lai, K.

129 5S p. S77-S78
article
338 PREVALENCE AND CHARACTERISTICS OF EOSINOPHILIC ESOPHAGITIS IN 2019 Miluski, T.

129 5S p. S79
article
339 PREVALENCE OF ALLERGIES ON PEDIATRIC PATIENTS WITH ATOPIC DERMATITIS AND EOSINOPHILIC ESOPHAGITIS Velazquez, V.

129 5S p. S75-S76
article
340 PRIMARY HYPERPARATHYROIDISM AS A RARE INTRINSIC CAUSE OF CHRONIC URTICARIA AND ANGIOEDEMA Moyo, J.

129 5S p. S116
article
341 PRIMARY IMMUNODEFICIENCY DISEASE MORTALITY TRENDS ACROSS EU15+ COUNTRIES: AN EPIDEMIOLOGICAL ANALYSIS Salciccioli, I.

129 5S p. S57
article
342 PROFOUND LYMPHOPENIA AND HYPOGAMMAGLOBULINEMIA ASSOCIATED WITH ROTAVIRUS VACCINATION Shah, R.

129 5S p. S123
article
343 PROGESTOGEN HYPERSENSITIVITY – A CASE SERIES Botero, A. Hernandez

129 5S p. S80
article
344 PROLONGED BLOOD HYPEREOSINOPHILIA AND EOSINOPHILIC ENTEROCOLITIS FROM PINWORM INFECTION ASSOCIATED WITH IGA AND IGE DEFICIENCY Sanderson, H.

129 5S p. S108
article
345 QUALITY OF LIFE IMPROVEMENTS WITH BIOLOGIC INITIATION AMONG SPECIALIST-TREATED US PATIENTS WITH SEVERE ASTHMA Soong, W.

129 5S p. S45-S46
article
346 RACIAL DIFFERENCES IN FOOD ALLERGY DIAGNOSIS AMONG CHILDREN WITH ATOPIC DERMATITIS INDEPENDENT OF SOCIOECONOMIC CONDITION Stephen, E.

129 5S p. S60-S61
article
347 RACIAL DISPARITIES IN FOOD ALLERGY ANAPHYLAXIS EDUCATION AND MANAGEMENT AMONG A NATIONALLY REPRESENTATIVE SAMPLE Klein, S.

129 5S p. S68
article
348 RAISING AWARENESS AMONG MEDICAL RESIDENTS TO DE-LABEL PENICILLIN ALLERGY Nguyen, V.

129 5S p. S69
article
349 RANDOMIZED, CONTROLLED TRIAL OF EXHALATION DELIVERY SYSTEM WITH FLUTICASONE FOR CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS Peters, A.

129 5S p. S73
article
350 RAPID AND SUSTAINED REDUCTIONS IN HEREDITARY ANGIOEDEMA ATTACK RATES WITH LONG-TERM BEROTRALSTAT: REAL-WORLD OUTCOMES Lumry, W.

129 5S p. S10
article
351 RARE CASE OF HOMOZYGOUS IFNAR1 DEFICIENCY IN A SAMOAN CHILD WITH DISSEMINATED VARICELLA AFTER VACCINATION Revier, M.

129 5S p. S135-S136
article
352 RARE CUTANEOUS ADVERSE REACTION TO ROUTINE IMMUNIZATIONS LEADING TO HYPER IGE SYNDROME (HIES) DIAGNOSIS Eremija, J.

129 5S p. S125
article
353 RARE MUTATION IN AIRE GENE IDENTIFIED IN PATIENT WITH VERY EARLY ONSET IBD Chernikova, D.

129 5S p. S145
article
354 REAL-WORLD BENRALIZUMAB EFFECTIVENESS AMONG ASTHMA PATIENTS WITH COMORBID NASAL POLYPS: RESULTS FROM THE ZEPHYR2 STUDY Carstens, D.

129 5S p. S37-S38
article
355 REAL-WORLD EFFECTIVENESS OF DUPILUMAB AND OTHER BIOLOGICS ON ASTHMA EXACERBATIONS AND STEROID PRESCRIPTIONS: US-ADVANTAGE STUDY Bleecker, E.

129 5S p. S38
article
356 REAL-WORLD EFFECTIVENESS OF DUPILUMAB IN ASTHMA: FINDINGS FROM THE US ADVANTAGE STUDY Blaiss, M.

129 5S p. S38
article
357 REAL-WORLD EFFECTIVENESS OF DUPILUMAB ON ORAL CORTICOSTEROID USE IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA Pawar, A.

129 5S p. S48-S49
article
358 REAL WORLD EFFECTIVENESS OF MEPOLIZUMAB IN PATIENTS WITH ALLERGIC AND NON-ALLERGIC ASTHMA Silver, J.

129 5S p. S42-S43
article
359 REAL-WORLD TREATMENT BURDEN ASSOCIATED WITH PARENTERAL ON-DEMAND THERAPIES FOR HEREDITARY ANGIOEDEMA Tachdjian, R.

129 5S p. S15-S16
article
360 REAL-WORLD UTILIZATION OF IMMUNE GLOBULIN INTRAVENOUS 10% AT PHYSICIAN OFFICE INFUSION CENTERS Herrscher, R.

129 5S p. S53-S54
article
361 REAL-WORLD UTILIZATION OF IMMUNE GLOBULIN SUBCUTANEOUS 16.5% IN TREATMENT-NAÏVE PRIMARY IMMUNODEFICIENT PATIENTS Langford, J.

129 5S p. S53
article
362 RECALL URTICARIA IN PATIENT WITH CELIAC DISEASE Lee, M.

129 5S p. S112
article
363 RECURRENT APHTHOUS STOMATITIS AND ORAL CANDIDIASIS DUE TO STAT1 MUTATION Wang, Q.

129 5S p. S125
article
364 RECURRENT CRYPTOCOCCAL MENINGITIS IN PATIENT WITH ANTI-GM-CSF AUTOANTIBODIES Ferretti-Gallon, J.

129 5S p. S134-S135
article
365 RECURRENT FUNGAL INFECTIONS FROM BIRTH TO ADULTHOOD: UNKNOWN DIAGNOSIS UNTIL GENETIC TESTING FOR STAT-1 VARIANTS Su, C.

129 5S p. S126
article
366 RECURRENT LUNG INFECTIONS IN A HETEROZYGOUS CARRIER OF NOVEL NSMCE3 MUTATION. Abellard, A.

129 5S p. S125-S126
article
367 REDUCED COVID-19 VACCINE RESPONSE IN PATIENT TREATED WITH DUPILUMAB FOR IGG4 RELATED DISEASE. Abadeh, A.

129 5S p. S160
article
368 Reduction in Reaction Severity Following 12 Months of Epicutaneous Immunotherapy with Peanut Patch in Toddlers Begin, P.

129 5S p. S64-S65
article
369 REDUCTIONS IN EXACERBATIONS OF SEVERE ASTHMA PATIENTS TREATED WITH BENRALIZUMAB – ZEPHYR 3 Carstens, D.

129 5S p. S39
article
370 REFERRAL FOR SUN ALLERGY – A CASE OF ERYTHROPOIETIC PROTOPORPHYRIA Bourgoyne, K.

129 5S p. S155
article
371 REFLECTANCE CONFOCAL MICROSCOPY OF ALLERGIC CONTACT DERMATITIS TO MANGO SAP (MANGIFERA INDICA) Wei, G.

129 5S p. S157
article
372 REFRACTORY CHRONIC SPONTANEOUS URTICARIA AFTER TREATED GRAVES' DISEASE Cheng, S.

129 5S p. S116
article
373 RELIABILITY OF BANANA-SPECIFIC IGE TESTING PRIOR TO ORAL FOOD CHALLENGE Patel, N.

129 5S p. S63
article
374 RELIABILITY OF PUMPKIN-SPECIFIC IGE AND TOTAL IGE PRIOR TO ORAL FOOD CHALLENGE Patel, N.

129 5S p. S62-S63
article
375 REMIBRUTINIB IMPROVES CHRONIC SPONTANEOUS URTICARIA IN PATIENTS IRRESPECTIVE OF CU-INDEX: RESULTS FROM PHASE 2B STUDY Carr, W.

129 5S p. S11
article
376 REMIBRUTINIB IMPROVES CHRONIC SPONTANEOUS URTICARIA IN PATIENTS WITH LOW OR HIGH IGE Hayama, K.

129 5S p. S31-S32
article
377 REMIBRUTINIB TREATMENT IMPROVES SLEEP AND ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA PATIENTS: PHASE 2B STUDY RESULTS Clore, L.

129 5S p. S32
article
378 RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA Beloglazov, V.

129 5S p. S56
article
379 RESULTS OF A PHASE 4 STUDY OF IMMUNOGLOBULIN [HUMAN] SUBCUTANEOUS FOR PATIENTS REQUIRING IMMUNOGLOBULIN Isaac, M.

129 5S p. S57
article
380 RESULTS OF A REPEAT DOSE STUDY ON THE PHARMACOKINETICS OF A SUBLINGUAL FILM USING A NOVEL PRODRUG OF EPINEPHRINE (DESF) Oppenheimer, J.

129 5S p. S21
article
381 RETROSPECTIVE REVIEW OF ORAL FOOD CHALLENGE OUTCOMES IN A MILITARY MEDICAL CENTER Miller, M.

129 5S p. S6
article
382 REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS AlOtaibi, I.

129 5S p. S18
article
383 RHABDOMYOLYSIS INDUCED URTICARIA: A COMPELLING REASON TO PROCRASTINATE - A CASE REPORT Nalakonda, G.

129 5S p. S115
article
384 RISK OF ANAPHYLAXIS TO THE COMPONENTS OF THE COVID-19 VACCINE: A STUDY IN MEXICAN POPULATION Henriquez, R. Lopez

129 5S p. S21
article
385 SAFETY OF CEFAZOLIN PERIOPERATIVE PROPHYLAXIS IN PLASTIC SURGERY PATIENTS WITH PENICILLIN ALLERGY Dong, R.

129 5S p. S18
article
386 SAMTER'S TRIAD IN A 9 YEARS-OLD PATIENT: A CASE REPORT Caimmi, D.

129 5S p. S118
article
387 SAP DEFICIENCY PRESENTING IN A CHILD WITH RECURRENT DIFFUSE LARGE B CELL LYMPHOMA Gunderman, L.

129 5S p. S145-S146
article
388 SARS-COV-2 ANTIBODY LEVELS CONTINUE TO RISE IN IMMUNE GLOBULIN PREPARATIONS Wang, Q.

129 5S p. S5
article
389 SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE Eremija, J.

129 5S p. S162-S163
article
390 SCIDISH – AN UNPREDICTED CASE OF T CELL LYMPHOPENIA, HYPOCALCEMIA, AND SKELETAL ANOMALIES Tran, N.

129 5S p. S129
article
391 SECONDARY URTICARIAL VASCULITIS AND CHRONIC SPONTANEOUS URTICARIA ASSOCIATED WITH COVID-19 VACCINATION Chang, T.

129 5S p. S94
article
392 SERUM IGM DEFICIENCY ASSOCIATED WITH CONNEXIN MUTATION IN AN 18-YEAR-OLD MALE Sarkaria, S.

129 5S p. S122
article
393 SERUM LEVELS OF PRO- (TNF-A) AND ANTI-INFLAMMATORY (TGF-SS) CYTOKINES AFTER ACUTE KIDNEY INJURY IN CHILDREN Driianska, V.

129 5S p. S55
article
394 SERUM SICKNESS AFTER COSMETIC ONABOTULINUMTOXIN A USE DeLuca-Pytell, D.

129 5S p. S91
article
395 SESAME SEED ALLERGY RESOLUTION IN TODDLERHOOD WITH NON- IGE ALLERGY COMORBIDITIES; AN EXCEPTION OR RULE? Rambharack, N.

129 5S p. S151
article
396 SEVERE ATOPIC DERMATITIS IMPROVED WITH OMALIZUMAB TREATMENT OF CHOLINERGIC URTICARIA Boateng, E.

129 5S p. S114
article
397 SEVERE DIFFUSE DESQUAMATING RASH IN AN INFANT WITH ATOPIC DERMATITIS Lee, H.

129 5S p. S158
article
398 SEVERE INFLAMMATORY RESPONSE SYNDROME AFTER TMP-SMX IN A HEALTHY PATIENT Chen, C.

129 5S p. S103
article
399 SEVERE PRURITUS AS A PRESENTING SYMPTOM OF HODGKIN'S LYMPHOMA Smith, R.

129 5S p. S154
article
400 SEVERITY OF INITIAL EGG REACTION MAY PREDICT INCREASED RISK OF BAKED EGG ORAL CHALLENGE REACTIONS Hyser, E.

129 5S p. S62
article
401 SHORT-ACTING BETA2-AGONIST USE REDUCTION AMONG PATIENTS WITH UNCONTROLLED ASTHMA USING A RELIEVER DIGITAL SYSTEM Hoyte, F.

129 5S p. S40
article
402 SICK BUILDING SYNDROME: HOW IS IT AFFECTED BY AIRBORNE POLLEN, INDOOR AND OUTDOOR POLLUTANTS? Salcido, G. Hernandez

129 5S p. S71
article
403 SINGLE VERSUS MULTI-ALLERGEN ORAL IMMUNOTHERAPY FOR TREATMENT OF FOOD ALLERGY: A RETROSPECTIVE COHORT STUDY Larson, E.

129 5S p. S58
article
404 SNIFFING AROUND FOR CLINICAL SCREENING MARKERS TO PREDICT AERD IN CRSWNP PATIENTS Coyle, T.

129 5S p. S72
article
405 SOCIAL MEDIA USE AMONG PARENTS OF FOOD ALLERGIC CHILDREN Stukus, D.

129 5S p. S59
article
406 SPECIFIC FOOD ALLERGENS ASSOCIATED WITH CLINICAL SENSITIZATION AMONG PATIENTS PRESENTING TO HOSPITALS IN HYDERABAD, INDIA Dadha, P.

129 5S p. S67
article
407 SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING Musa, A.

129 5S p. S8
article
408 STAT1 GOF DISEASE PRESENTING WITH RECURRENT CUTANEOUS CELLULITIS AND UNREMARKABLE BASIC IMMUNOLOGY LABORATORY VALUES Desai, S.

129 5S p. S141-S142
article
409 STEROIDAL AND NONSTEROIDAL AROMATASE INHIBITORS INDUCED DERMATITIS- A CASE REPORT OF CROSS-REACTIVITY Ebrahim, M.

129 5S p. S84-S85
article
410 STEROID SPARING STRATEGY WITH DUAL BIOLOGICS IN TREATING HYPEREOSINOPHILLIC SYNDROME Hsueh, J.

129 5S p. S163
article
411 STUCK BETWEEN A BLOCK AND A HARD PLACE: VACCINE-HYPERSENSITIVITY TESTING IN CHILDREN WITH CARDIAC DISEASE Rana, R.

129 5S p. S97
article
412 STUDY OF THE NUCLEOTIDE POLYMORPHISM IL-4 RS2243250 (C-589T) FREQUENCY IN PATIENTS WITH ALLERGIC RESPIRATORY Novikova, T.

129 5S p. S49
article
413 SUCCESSFUL IMIGLUCERASE DESENSITIZATION IN A PATIENT WITH SEVERE ARTHRALGIA AND MYALGIA Foster, K.

129 5S p. S93
article
414 SUCCESSFUL TREATMENT OF REFRACTORY PEDIATRIC EOSINOPHILIC ESOPHAGITIS WITH DUPILUMAB Venkatesh, S.

129 5S p. S161
article
415 SUCCESSFUL TREATMENT OF SOLAR URTICARIA WITH OMALIZUMAB Mullur, J.

129 5S p. S118
article
416 SUCCESSFUL USE OF ICATIBANT PRE-TREATMENT TO PREVENT SYSTEMIC REACTION DURING LDL APHERESIS Davidson, L.

129 5S p. S99
article
417 SUGAMMADEX ANAPHYLAXIS Goodman, B.

129 5S p. S90
article
418 SUSTAINED CLINICAL BENEFITS IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 24 WEEKS POST-MEPOLIZUMAB TREATMENT Desrosiers, M.

129 5S p. S71-S72
article
419 SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE WITH CONTINUED LANADELUMAB TREATMENT IN HEREDITARY ANGIOEDEMA Watt, M.

129 5S p. S27
article
420 SWITCHING BIOLOGICS FOR ASTHMA Lopez, M.

129 5S p. S51
article
421 SYMMETRIC DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA (SDRIFE) INDUCED BY CIPROFLOXACIN Davila, N. Fernandez

129 5S p. S94
article
422 SYNDROME OF THYROID AUTOIMMUNITY AND IDIOPATHIC CHRONIC URTICARIA AND ANGIOEDEMA Angirekula, A.

129 5S p. S115
article
423 SYSTEMIC LUPUS ERYTHEMATOSUS IS ASSOCIATED WITH INCREASED RISK FOR RADIOCONTRAST ALLERGY Rawal, N.

129 5S p. S20-S21
article
424 SYSTEMIC LUPUS ERYTHEMATOSUS MIMICKING A HEMATOLOGIC MALIGNANCY IN AN AFRICAN AMERICAN 12-YEAR-OLD MALE Caha, M.

129 5S p. S133
article
425 SYSTEMIC MASTOCYTOSIS PRESENTING WITH KOUNIS SYNDROME AND REFRACTORY SHOCK Sanchez, D.

129 5S p. S163-S164
article
426 SYSTEMIC MASTOCYTOSIS WITH CONCURRENT ALPHA-GAL ASSOCIATED ANAPHYLAXIS Mathew, S.

129 5S p. S87
article
427 Table of Contents Medically Challenging Cases
129 5S p. S82
article
428 Table of Contents Oral Abstracts
129 5S p. S2
article
429 Table of Contents Research Abstracts
129 5S p. S14
article
430 THE EFFECT OF DUPILUMAB ON LUNG FUNCTION BY ALLERGEN SENSITIZATION STATUS IN PEDIATRIC ASTHMA Phipatanakul, W.

129 5S p. S47-S48
article
431 THE FIRST REPORT OF ANGIOEDEMA AND ANAPHYLAXIS WITH TEMPORAL ASSOCIATION TO SEMAGLUTIDE Feinstein, J.

129 5S p. S85
article
432 THE "FLARE-UP PHENOMENON": NEW ONSET OF DISTANT DERMATITIS DURING PATCH TESTING Trogen, B.

129 5S p. S159
article
433 THE IMPACT OF COVID-19 PANDEMIC ISOLATION MEASURES ON PEDIATRIC ASTHMA ADMISSIONS Raja, S.

129 5S p. S49
article
434 THE IMPORTANCE OF B CELLS IN OVERCOMING COVID-19 INFECTION IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS. Brozyna, J.

129 5S p. S53
article
435 THE LEARN EARLY PROJECT: LEARNING EDUCATORS ANAPHYLAXIS RESPONSE NEEDS Kaman, K.

129 5S p. S68-S69
article
436 THE MILK PROBLEM IN HEINER SYNDROME Molina, M. Forero

129 5S p. S149
article
437 THE ROLE OF LABORATORY EVALUATION IN THE DIAGNOSIS AND MANAGEMENT OF NLRP12- ASSOCIATED AUTOINFLAMMATORY DISEASE Coletta, C.

129 5S p. S132-S133
article
438 THE ROLE OF PRESEPSIN IN IMMUNOSUPPRESSION IN SEPSIS AND SEPTIC SHOCK PATIENTS Trusevich, M.

129 5S p. S55-S56
article
439 THE SEVERITY OF ALLERGIC RHINITIS IS RELATED TO SLEEP DISTURBANCES IN KOREAN CHILDREN AND ADOLESCENTS Rha, Y.

129 5S p. S71
article
440 THE SUSTAINED OCS-SPARING EFFECT OF MEPOLIZUMAB: RESULTS FROM THE REAL-WORLD REALITI-A STUDY AT 2 YEARS Pollard, S.

129 5S p. S43
article
441 THE UNIQUE ROLE IMMUNOLOGISTS PLAY IN NAVIGATING THE CARE OF CRITICALLY ILL PEDIATRIC PATIENTS Gaberino, C.

129 5S p. S139
article
442 THE USE OF LANADELUMAB AS TREATMENT IN A PATIENT WITH ACQUIRED ANGIOEDEMA Osman, F.

129 5S p. S118
article
443 THE USE OF MULTI-OMICS TO IDENTIFY PREDICTIVE FACTORS FOR FOOD REACTIONS Beheshti, R.

129 5S p. S6
article
444 THROMBOCYTOPENIA, HYPOGAMMAGLOBULINEMIA, AND POOR VACCINE RESPONSE IN A PATIENT WITH TAKENOUCHI-KOSAKI SYNDROME McAuley, J.

129 5S p. S144
article
445 TIME BEFORE USE OF EPINEPHRINE INJECTABLE DEVICES AND TRIGGERS DRIVING USE: A PATIENT/CAREGIVER SURVEY Rooney, E.

129 5S p. S16-S17
article
446 TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA Casale, T.

129 5S p. S26-S27
article
447 Title page
129 5S p. S1
article
448 TO CHALLENGE OR AVOID? POSSIBLE ASPIRIN ALLERGY IN PATIENTS WITH CHRONIC IDIOPATHIC URTICARIA AND ANGIOEDEMA Wealing, J.

129 5S p. S84
article
449 TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING Hamel, B.

129 5S p. S15
article
450 TOO NEAR, YET TOO FAR: 22Q DELETION AND VELOCARDIOFACIAL SYNDROME MIMIC Kerber, A.

129 5S p. S134
article
451 TOXIC EPIDERMAL NECROLYSIS IN A PATIENT WITH GRAFT-VERSUS-HOST DISEASE Link, M.

129 5S p. S104
article
452 TOXIC EPIDERMAL NECROLYSIS INDUCED BY PHENYTOIN: AN UNCOMMONLY USED ANTIEPILEPTIC DRUG IN HIGH-INCOME COUNTRIES Ratchataswan, T.

129 5S p. S92
article
453 TRAUMATIC “ANGIOEDEMA”: EXTENSIVE SUBCUTANEOUS EMPHYSEMA MASQUERADING AS ANGIOEDEMA Khakwani, Z.

129 5S p. S110
article
454 TREATMENT OF ASTHMA MIGHT HAVE DELAYED END-ORGAN DAMAGE IN THE PATIENT WITH LYMPHOCYTIC HYPEREOSINOPHILIC SYNDROME Kosinski, S.

129 5S p. S138
article
455 TREATMENT OF DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) WITH MEPOLIZUMAB Peters, A.

129 5S p. S89
article
456 TREATMENT OF DUPILUMAB-ASSOCIATED KERATOCONJUNCTIVITIS Blanco, J.

129 5S p. S159
article
457 TREATMENT OF HYPEREOSINOPHILIA WITH MEPOLIZUMAB IN A 6-YEAR-OLD BOY Eubanks, J.

129 5S p. S108
article
458 TWO-STEP NONSTEROIDAL ANTI-INFLAMMATORY DRUG CHALLENGE DURING PREGNANCY: A CASE SERIES Li, L.

129 5S p. S85
article
459 TYPE I HEREDITARY ANGIOEDEMA ASSOCIATED WITH SERPING1 GENE MUTATION Hauk, S.

129 5S p. S144
article
460 TYPE II AND III KOUNIS SYNDROME AFTER PEANUT ANAPHYLAXIS Arends, J.

129 5S p. S85
article
461 UNDERSTANDING COMMUNITY-LEVEL IMPACTS ON FOOD ALLERGY MANAGEMENT AND OUTCOMES VIA A NOVEL COMMUNITY SUPPORT SCALE Yost, J.

129 5S p. S68
article
462 UNDERSTANDING HOST-MICROBIAL INTERACTIONS THAT PREDISPOSE INFANTS TO ATOPIC DERMATITIS Beheshti, R.

129 5S p. S7
article
463 UNDETECTABLE IGE AS A SENTINEL BIOMARKER FOR HUMORAL IMMUNODEFICIENCY Makin, T.

129 5S p. S5
article
464 UNEXPECTED DIAGNOSIS FOLLOWING IMMUNODEFICIENCY WORK-UP Miller, C.

129 5S p. S123
article
465 UNRAVELING THE CAUSE OF A KINDRED WITH CHRONIC CANDIDIASIS Hall, G.

129 5S p. S132
article
466 UNRECOGNIZED PARASITIC INFECTION AS A CAUSE OF PERSISTENT EOSINOPHILIA IN AN INNER-CITY ALLERGY CLINIC POPULATION Regula, P.

129 5S p. S8-S9
article
467 UNUSUAL CAUSE OF PERIORBITAL ANGIOEDEMA. Carpenter, T.

129 5S p. S134
article
468 UNUSUAL PRESENTATION OF HETEROZYGOUS RAG1 DEFICIENCY Burnett-Stinson, A.

129 5S p. S141
article
469 URTICARIAL VASCULITIS MASQUERADING AS TYPICAL ACUTE URTICARIA Wong, K.

129 5S p. S114-S115
article
470 USABILITY SCORES OF A RELIEVER DIGITAL SYSTEM IN PATIENTS WITH UNCONTROLLED ASTHMA Hoyte, F.

129 5S p. S42
article
471 USING AREA DEPRIVATION INDEX TO ASSESS RACIAL DISPARITIES IN ASTHMA AMONG CHILDREN WITH FOOD ALLERGY Dileep, A.

129 5S p. S40
article
472 USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY Mohammed, S.

129 5S p. S16
article
473 UTILIZATION OF A HOSPITALIST DRIVEN PENICILLIN SKIN TESTING PROTOCOL TO PROMOTE ANTIBIOTIC STEWARDSHIP Indaram, M.

129 5S p. S69
article
474 VALUES AND PREFERENCES OF PATIENTS AND CAREGIVERS REGARDING TREATMENT OF ATOPIC DERMATITIS: A SYSTEMATIC REVIEW Maleki-Yazdi, K.

129 5S p. S74-S75
article
475 VANISHING VITILIGO? DUPILUMAB AND AEROALLERGEN IMMUNOTHERAPY IMPROVE LONGSTANDING VITILIGO Miller, M.

129 5S p. S154
article
476 VENOM IMMUNOTHERAPY: SELECTIVE DESENSITIZATION Hein, N.

129 5S p. S103
article
477 WHAT ARE PATIENTS SEARCHING ON INTERNET IN RELATION TO URTICARIA? AN INFODEMIOLOGY ANALYSIS Maurer, M.

129 5S p. S34
article
478 WHAT TO GIVE NEXT? THE CHALLENGE OF SEVERE PERIOPERATIVE DRUG REACTIONS IN PEDIATRIC PATIENTS Navard-Keck, A.

129 5S p. S99
article
479 WHEN A SWEET RASH LEADS TO A SOUR DIAGNOSIS Nguyen, V.

129 5S p. S128-S129
article
480 WHY DO GENERALISTS ORDER FOOD ALLERGEN IGE PANELS? A QUALITY IMPROVEMENT NEEDS ASSESSMENT Dave, R.

129 5S p. S64
article
481 X-LINKED INHIBITOR OF APOPTOSIS DEFICIENCY IN A PATIENT WITH ADULT-ONSET RECURRENT FEBRILE ILLNESSES Patel, N.

129 5S p. S124
article
482 X-LINKED LYMPHOPROLIFERATIVE DISEASE: DIAGNOSTIC CHALLENGE IN A MIDDLE-AGED MALE Van Meerbeke, S.

129 5S p. S140
article
483 XMEN DISEASE: MAGT1 MUTATION IN A CHILD WITH HYPOGAMMAGLOBULINEMIA Serrano-Santiago, S.

129 5S p. S144-S145
article
                             483 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands